Matthew W. Carroll

Matthew W. Carroll

Auto-generated profile, based on publicly available information

Matthew W. Carroll

Edmonton Pediatric IBD Clinic (EPIC), Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2015 in Journal of Crohn's and Colitis
Verified
Journal Article
Open access
PDF file
MAMisagh Alipour
Misagh Alipour
DZDeenaz Zaidi
Deenaz Zaidi
RVRosica Valcheva
Rosica Valcheva
JJJuan Jovel
Juan Jovel
IMInés Martínez
Inés Martínez
EWEytan Wine
Eytan Wine
Ulcerative colitis [UC] is associated with colonic mucosa barrier defects and bacterial dysbiosis, but these features may simply be the result of inflammation. Therefore, we sought to assess whether these features are inherently abrogated in the terminal ileum [TI] of UC patients, where inflammation is absent. TI biopsies from paediatric inflammatory bowel disease [IBD] subsets [Crohn’s disease [CD; n = 13] and UC [ n = 10]], and non-IBD disease controls [ n = 12] were histologically graded, and alcian blue/periodic acid-Schiff stained biopsies were quantified. The mucosal barrier was assessed for mucin [MUC2], immunoglobulin [Ig]A, IgG, and total bacteria (fluorescence in-situ hybridisation [FISH probe EUB338]) by immunofluorescence. The regulation of mucin secretion was investigated by NLRP6 gene expression and immunofluorescence. The composition of the active mucosa-associated microbiota was explored by sequencing the 16S rRNA amplicon generated from total RNA. Despite the absence of ileitis, UC patients displayed ileal barrier depletion illustrated by reductions in mucin-containing goblet cells and mucin production and altered epithelial NLRP6 expression. In both CD patients with ileitis and UC patients with normal histology, bacteria coated with IgA and IgG penetrated the TI mucin layer. Biopsy 16S rRNA sequencing revealed a reduction in α-diversity by three methods [Shannon, Simpson, and Equitability indices] between UC and non-IBD paediatric patients. These findings suggest an underlying defect in the UC-afflicted intestinal tract even in the absence of inflammation, implicating barrier and microbial changes as primary abnormalities in UC that may play a causative role in disease development.

1 November 2018 in Clinical Epidemiology
Verified
Journal Article
Open access
PDF file
EBEric I Benchimol
Eric I Benchimol
MKM. Ellen Kuenzig
M. Ellen Kuenzig
CBCharles N Bernstein
Charles N Bernstein
GNGeoffrey C Nguyen
Geoffrey C Nguyen
AGAstrid Guttmann
Astrid Guttmann
GKGilaad Kaplan
Gilaad Kaplan
Background and aims: Canada’s large geographic area and low population density pose challenges in access to specialized health care for remote and rural residents. We compared health services use, surgical rate, and specialist gastroenterologist care in rural and urban inflammatory bowel disease (IBD) patients in Canada. Methods: We used validated algorithms that were applied to population-based health administrative data to identify all people living with the following three Canadian provinces: Alberta, Manitoba, and Ontario (ON). We compared rural residents with urban residents for time to diagnosis, hospitalizations, outpatient visits, emergency department (ED) use, surgical rate, and gastroenterologist care. Multivariable regression compared the outcomes in rural/urban patients, controlling for confounders. Provincial results were meta-analyzed using random-effects models to produce overall estimates. Results: A total of 36,656 urban and 5,223 rural residents with incident IBD were included. Outpatient physician visit rate was similar in rural and urban patients. IBD-specific and IBD-related hospitalization rates were higher in rural patients (incidence rate ratio [IRR] 1.17, 95% CI 1.02–1.34, and IRR 1.27, 95% CI 1.04–1.56, respectively). The rate of ED visits in ON were similarly elevated for rural patients (IRR 1.53, 95% CI 1.42–1.65, and IRR 1.33, 95% CI 1.25–1.40). There were no differences in surgical rates or prediagnosis lag time between rural and urban patients. Rural patients had fewer IBD-specific gastroenterologist visits (IRR 0.79, 95% CI 0.73–0.84) and a smaller proportion of their IBD-specific care was provided by gastroenterologists (28.3% vs 55.2%, P<0.0001). This was less pronounced in children <10 years at diagnosis (59.3% vs 65.0%, P65 years (33.0% vs 59.2%, P<0.0001). Conclusion: There were lower rates of gastroenterologist physician visits , more hospitalizations, and greater rates of ED visits in rural IBD patients. These disparities in health services use result in costlier care for rural patients. Innovative methods of delivering gastroenterology care to rural IBD patients (such as telehealth, online support, and remote clinics) should be explored, especially for communities lacking easy access to gastroenterologists.

1 February 2024 in American Journal of Gastroenterology
Verified
Journal Article
Open access
SCStephanie Coward
Stephanie Coward
EBEric I. Benchimol
Eric I. Benchimol
CBCharles N. Bernstein
Charles N. Bernstein
AAAntonio Avina-Zubieta
Antonio Avina-Zubieta
ABAlain Bitton
Alain Bitton
O(on behalf of the Canadian Gastro-Intestinal Epidemiology Consortium (CanGIEC)
on behalf of the Canadian Gastro-Intestinal Epidemiology Consortium (CanGIEC)
INTRODUCTION: Canada has a high burden of inflammatory bowel disease (IBD). Historical trends of IBD incidence and prevalence were analyzed to forecast the Canadian burden over the next decade. METHODS: Population-based surveillance cohorts in 8 provinces derived from health administrative data assessed the national incidence (2007–2014) and prevalence (2002–2014) of IBD. Autoregressive integrated moving average models were used to forecast incidence and prevalence, stratified by age, with 95% prediction intervals (PI), to 2035. The average annual percentage change (AAPC) with 95% confidence interval (CI) was calculated for the forecasted incidence and prevalence. RESULTS: The national incidence of IBD is estimated to be 29.9 per 100,000 (95% PI 28.3–31.5) in 2023. With a stable AAPC of 0.36% (95% CI −0.05 to 0.72), the incidence of IBD is forecasted to be 31.2 per 100,000 (95% PI 28.1–34.3) in 2035. The incidence in pediatric patients (younger than 18 years) is increasing (AAPC 1.27%; 95% CI 0.82–1.67), but it is stable in adults (AAPC 0.26%; 95% CI −0.42 to 0.82). The prevalence of IBD in Canada was 843 per 100,000 (95% PI 716–735) in 2023 and is expected to steadily climb (AAPC 2.43%; 95% CI 2.32–2.54) to 1,098 per 100,000 (95% PI 1,068–1,127) by 2035. The highest prevalence is in seniors with IBD (1,174 per 100,000 in 2023; AAPC 2.78%; 95% CI 2.75–2.81). DISCUSSION: Over the next decade, the Canadian health care systems will contend with the juxtaposition of rising incidence of pediatric IBD and a rising prevalence of overall IBD driven by the aging population.

1 May 2016 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
MNMaría E Negrón
María E Negrón
ARAli Rezaie
Ali Rezaie
HBHerman Wildrik Barkema
Herman Wildrik Barkema
KRKevin Rioux
Kevin Rioux
JBJeroen De Buck
Jeroen De Buck
GKGilaad Kaplan
Gilaad Kaplan
Clostridium difficile (C. difficile) may worsen the prognosis of ulcerative colitis (UC). The objectives of this study were to: (i) validate the International Classification of Diseases-10 (ICD-10) code for C. difficile; (ii) determine the risk of C. difficile infection after diagnosis of UC; (iii) evaluate the effect of C. difficile infection on the risk of colectomy; and (iv) assess the association between C. difficile and postoperative complications. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated by comparing ICD-10 codes for C. difficile with stool toxin tests. A population-based surveillance cohort of newly diagnosed UC patients living in Alberta, Canada were identified from 2003 to 2009 (n=1,754). The effect of a C. difficile infection on colectomy was modeled using competing risk survival regression after adjusting for covariates. The effect of a C. difficile infection on postoperative complications was assessed using a mixed effects logistic regression model. The sensitivity, specificity, PPV, and NPV of the ICD-10 code for C. difficile were 82.1%, 99.4%, 88.4%, and 99.1%, respectively. The risk of C. difficile infection within 5 years of diagnosis with UC was 3.4% (95% confidence interval (CI): 2.5–4.6%). The risk of colectomy was higher among UC patients diagnosed with C. difficile (sub-hazard ratio (sHR)=2.36; 95% CI: 1.47–3.80). C. difficile increased the risk of postoperative complications (odds ratio=4.84; 95% CI: 1.28–18.35). C. difficile was associated with mortality (sHR=2.56 times; 95% CI: 1.28–5.10). C. difficile diagnosis worsens the prognosis of newly diagnosed patients with UC by increasing the risk of colectomy, postoperative complications, and death.

1 April 2013 in Genetics in Medicine
Verified
Journal Article
Closed access
CWChristine S. van der Werf
Christine S. van der Werf
YSYunia Sribudiani
Yunia Sribudiani
JVJoanne Verheij
Joanne Verheij
MCMatthew Carroll
Matthew Carroll
EOEdward O’lOughlin
Edward O’lOughlin
RHRobert M.W. Hofstra
Robert M.W. Hofstra

1 April 2014 in The Journal of Pediatrics
Verified
Journal Article
Closed access
KWKirstin E. Wingate
Kirstin E. Wingate
KJKevan Jacobson
Kevan Jacobson
RIRobert Issenman
Robert Issenman
MCMatthew Carroll
Matthew Carroll
CBCollin Barker
Collin Barker
TGTim Green
Tim Green